nonlinear regression with the log(inhibitor) versus response–variable slope curve-fitting algorithm in graphpad prism (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
nonlinear regression with the log(inhibitor) versus response–variable slope curve-fitting algorithm in graphpad prism
Nonlinear Regression With The Log(inhibitor) Versus Response–Variable Slope Curve Fitting Algorithm In Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/curve+fitting+algorithm/nonlinear+regression+log+agonist++vs++response/pmc12267055-326-18-21
Average 90 stars, based on 1 article reviews
Nonlinear Regression With The Log(inhibitor) Versus Response–Variable Slope Curve Fitting Algorithm In Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/curve+fitting+algorithm/nonlinear+regression+log+agonist++vs++response/pmc12267055-326-18-21
Average 90 stars, based on 1 article reviews
nonlinear regression with the log(inhibitor) versus response–variable slope curve-fitting algorithm in graphpad prism - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Concentration Assay:Article Title: Enhancing Antibiotic-Resistant Bacterial Infection Therapy: Self-Assembling Gemini Quaternary Ammonium-Functionalized Peptide Nanoassemblies with Multiple Antibacterial Mechanisms. Article Snippet: .. The lowest concentration inhibiting 50% of ribosome activity (IC50) was calculated using nonlinear regression log(inhibitor) vs. response (three parameters) by Activity Assay:Article Title: Enhancing Antibiotic-Resistant Bacterial Infection Therapy: Self-Assembling Gemini Quaternary Ammonium-Functionalized Peptide Nanoassemblies with Multiple Antibacterial Mechanisms. Article Snippet: .. The lowest concentration inhibiting 50% of ribosome activity (IC50) was calculated using nonlinear regression log(inhibitor) vs. response (three parameters) by other:Article Title: High-Throughput Screens of Repurposing Hub and DOS Chemical Libraries Reveal Compounds with Novel and Potent Inhibitory Activity Against the Essential Non-Neuronal Acetylcholinesterase of Schistosoma mansoni (SmTAChE) Article Snippet: Additional IC 50 graphs were generated using nonlinear regression analysis of a log[I] vs. normalized response-variable slope using Article Title: A general assay platform to study protein pharmacology using ligand-dependent structural dynamics Article Snippet: Concentration response curves (CRCs) for inhibitors or ligands to specific targets were fit and IC 50 or SDR 50 values were initially calculated using the standard Hill equation, e.g., nonlinear regression log(compound) vs. response -- variable slope (four parameters) fit (Supplementary Equation ( ) or bell fit (Supplementary Equation ( ) in Article Title: High-Throughput Screens of Repurposing Hub and DOS Chemical Libraries Reveal Compounds with Novel and Potent Inhibitory Activity Against the Essential Non-Neuronal Acetylcholinesterase of Schistosoma mansoni (SmTAChE). Article Snippet: Additional IC50 graphs were generated using nonlinear regression analysis of a log[I] vs. normalized response-variable slope using Generated:Article Title: Dihydromyricetin restores lysosomal function in Schwann cells to alleviate bortezomib-induced peripheral neuropathy via ERK/TFEB signaling. Article Snippet: Bortezomib (BTZ) serves as a first-line drug for multiple myeloma (MM) treatment by reversibly inhibiting of the proteasomes.. However, BTZ-induced peripheral neuropathy (BIPN) remains a significant toxicity concern, with its molecular mechanisms not fully elucidated, resulting in limited therapeutic options.. Dihydromyricetin (DHM) has been shown to alleviate neuropathic pain, but its potential effect on BIPN has not been investigated. |